Functional impairment · treatment of disordered and problem gambling
1 finding from 1 review
Responder status · treatment of disordered and problem gambling
It is very uncertain whether antidepressants changes responder status compared with placebo (very low certainty).
1 finding from 1 review
Suicide‐related outcomes Timing of outcome assessment: end of treatment (6 to 12 weeks treatment duration) · patients with borderline personality disorder
1 finding from 1 review
Psychosocial functioning Measured by: clinicians and self‐rated Timing of outcome assessment: end of treatment · patients with borderline personality disorder
1 finding from 1 review
Interpersonal problems Timing of outcome assessment: end of treatment (32 days to 24 weeks) · patients with borderline personality disorder
1 finding from 1 review
Attrition Timing of outcome assessment: end of treatment · patients with borderline personality disorder
Antidepressants may leads to higher attrition Timing of outcome assessment: end of treatment (5 weeks to… compared with placebo (low certainty).
1 finding from 1 review
Non‐serious adverse events Timing of outcome assessment: end of treatment · patients with borderline personality disorder
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
BPD symptom severity Measured by: clinicians and self‐rated Timing of outcome assessment: end of treatment · patients with borderline personality disorder
1 finding from 1 review
Deliberate self‐harm · patients with borderline personality disorder
1 finding from 1 review
Quality of life · children with asymptomatic flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Treatment success (caries lesion arrest or restoration survival) · children with asymptomatic flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · children with asymptomatic flat feet
It is very uncertain whether prefabricated foot orthoses changes withdrawal due to adverse events compared with shoes (very low certainty).
1 finding from 1 review
RR 0.99 [0.79, 1.23]
Studies not reported
Very low
Adverse events · children with asymptomatic flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events · children with asymptomatic flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Patient‐reported pain intensity or pain relief (VAS, NRS or categorical scale) · children with juvenile idiopathic arthritis and flat feet
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Function or disability (measured on 0 to 100‐point FFI; 0 = no disability) · children with juvenile idiopathic arthritis and flat feet
1 finding from 1 review
no estimate extracted
Studies not reported
Low
QoL · children with juvenile idiopathic arthritis and flat feet
2 findings from 1 review
no estimate extracted
Studies not reported
Low
no estimate extracted
Studies not reported
Low
Treatment success (measured on the 50FWT (seconds)) · children with juvenile idiopathic arthritis and flat feet
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Withdrawals due to adverse events · children with juvenile idiopathic arthritis and flat feet
Prefabricated foot orthoses showed no clear difference in withdrawal due to adverse events compared with shoes; GRADE not reported.
1 finding from 1 review
RR 0.72 [0.14, 3.61]
Studies not reported
GRADE not reported
Adverse events · children with juvenile idiopathic arthritis and flat feet
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found